Clinical Trial Update: A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA) [Phase 3]

View source ↗

Summary

Phase 3 study COURAGE-RA evaluates LNK01001 Capsule in adults with active rheumatoid arthritis; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• LNK01001 Capsule

Snippet

Sponsor: Lynk Pharmaceuticals Co., Ltd | Conditions: Rheumatoid Arthritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING